Viewing Study NCT02697357


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-01-02 @ 1:31 AM
Study NCT ID: NCT02697357
Status: COMPLETED
Last Update Posted: 2020-07-13
First Post: 2016-02-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Emotion Regulation Therapy to Address Distress Among Caregivers
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Overview

Official Title: Emotion Regulation Therapy to Address Distress Among Caregivers
Status: COMPLETED
Status Verified Date: 2020-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study is to adapt and pilot test a type of therapy called Emotion Regulation Therapy (ERT-C) for informal caregivers of patients with cancer. Informal caregivers include partners, family members, children, parents, and friends providing informal care to a patient. Providing care to someone with cancer can be difficult. The purpose of this intervention is to improve coping and physical well-being among caregivers, which in turn will allow them to provide better care for their loved ones. Investigators would also like to learn about biological factors like stress that may affect one's emotional and physical well-being. This study will allow to better understand caregivers needs, and further develop a program to provide services to caregivers within MSKCC community and nationwide.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: